What are the effects of exercise training in childhood cancer survivors? A systematic review
Autor: | Alejandro Lucia, Alba M. Herrera-Olivares, Pedro L. Valenzuela, Asunción Martín-Ruiz, Cecilia Rincón-Castanedo, Adrián Castillo-García, Javier S. Morales, Carmen Fiuza-Luces |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty Waist Childhood cancer Increased physical activity Psychological intervention Physical exercise law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Cancer Survivors law Neoplasms medicine Humans Adverse effect Niños Exercise business.industry Cáncer Deporte Ejercicio físico 030104 developmental biology Oncology 030220 oncology & carcinogenesis Niño Physical therapy business Childhood brain tumor |
Zdroj: | Cancer metastasis reviews. 39(1) |
ISSN: | 1573-7233 |
Popis: | This systematic review aimed to summarize evidence on the effects of physical exercise interventions in childhood cancer survivors (CCS) who had finished anticancer therapy ≥ 1 year before the study. Relevant articles were identified in the electronic databases PubMed, Web of Science, and SPORTDiscus (from inception to June 27, 2019). The PEDro scale was used to assess methodological quality. Twelve studies including 109 CCS met all inclusion criteria and were included in the systematic review. The quality of the included studies was overall low. Physical exercise improved endothelial function, reduced waist circumference, and waist-to-hip ratio and increased physical activity levels. Preliminary evidence was found regarding benefits on brain volume and structure after exercise interventions in childhood brain tumor survivors. Only two studies reported exercise-related adverse events. Physical exercise seems to be safe and effective for improving several health markers in CCS, but further high-quality research and especially randomized controlled trials are needed to confirm these results. Sin financiación 9.264 JCR (2020) Q1, 32/242 Oncology 2.555 SJR (2020) Q1, 30/211 Cancer Research No data IDR 2019 UEM |
Databáze: | OpenAIRE |
Externí odkaz: |